ZBNA
LGND icon

Zions Bancorporation, National Association’s Ligand Pharmaceuticals LGND Stock Holding History

Zions Bancorporation, National Association’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948 Hold
3
– – ﹤0.01% 1434
2026
Q1 		$599 Hold
3
– – ﹤0.01% 1417
2025
Q4 		$567 Buy
+3
New +$576 ﹤0.01% 1197

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Zions Bancorporation, National Association's LGND Position: Q2 2026 in Review

Zions Bancorporation, National Association held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 3 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

Zions Bancorporation, National Association first reported a position in LGND in Q4 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Zions Bancorporation, National Association held 3 shares of Ligand Pharmaceuticals worth $948 as of Q2 2026.
  • Zions Bancorporation, National Association left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1434 holding.
  • Zions Bancorporation, National Association first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.